Clinical ResearchCardiac ImagingPhase II Safety and Clinical Comparison With Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Flurpiridaz F 18 Positron Emission Tomography
Cardiac Imaging
Under an Elsevier user license
open archive
Key Words
flurpiridaz F 18
myocardial perfusion
SPECT
Abbreviations and Acronyms
AE
adverse event
CAD
coronary artery disease
CT
computed tomography
F-18
fluorine-18
ICA
invasive coronary angiography
MI
myocardial infarction
MPI
myocardial perfusion imaging
PCI
percutaneous coronary intervention
PET
positron emission tomography
QCA
quantitative coronary angiography
ROC
receiver-operating characteristic
SDS
summed different score
SPECT
single-photon emission computed tomography
SRS
summed rest score
SSS
summed stress score
Cited by (0)
Dr. Tamarappoo is currently at the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Dr. Maddahi has served as consultant to Lantheus Medical Imaging, Digirad, and Astellas; served on the Speakers' Bureau for Astellas; and contracted research with Lantheus Medical Imaging. Dr. Taillefer has served as consultant to and as a member of the scientific advisory board of Lantheus Medical Imaging. Dr. Gibson has received research grant funding from Lantheus Medical Imaging. Ms. Devine is an employee of Avid Radiopharmaceuticals. Drs. Bhat, Lazewatsky, and Washburn are employees of Lantheus Medical Imaging. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.